Cargando…

Cyclin D1 Expression and the Inhibitory Effect of Celecoxib on Ovarian Tumor Growth in Vivo

The report aims to investigate the relationship between the expression of cyclin D1 and Cyclooxgenase-2 (COX-2), thus to explore the molecular mechanisms of the antitumor efficacy of Celecoxib, a COX-2 inhibitor. Human ovarian SKOV-3 carcinoma cell xenograft-bearing mice were treated with Celecoxib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Jiang, Hong-Ru, Xu, Xiao-Li, Wang, Jie, Zhang, Jun, Liu, Mei-Lin, Zhai, Ling-Yun
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996781/ https://www.ncbi.nlm.nih.gov/pubmed/21152316 http://dx.doi.org/10.3390/ijms11103999

Ejemplares similares

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
por: Suri, Anuj, et al.
Publicado: (2016)

Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice
por: ZHANG, XIAO-QIAN, et al.
Publicado: (2015)

Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice
por: MENG, XIANYING, et al.
Publicado: (2014)

Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice
por: Wong, Tsz Yan, et al.
Publicado: (2014)

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
por: Basu, Gargi D, et al.
Publicado: (2005)

The molecular mechanisms of celecoxib in tumor development
por: Wen, Bin, et al.
Publicado: (2020)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
por: Fang, Meng, et al.
Publicado: (2023)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate—An In Vivo Evaluation
por: Zardán Gómez de la Torre, Teresa, et al.
Publicado: (2022)

Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice
por: Cheng, Pei-Hsin, et al.
Publicado: (2015)

MicroRNA-125b controls growth of ovarian granulosa cells in polycystic ovarian syndrome by modulating cyclin B1 expression
por: Deng, Jie, et al.
Publicado: (2019)

Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database
por: Quan, Li-Li, et al.
Publicado: (2021)

Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment
por: Ren, Fuqiang, et al.
Publicado: (2014)

Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
por: Barbieri, F., et al.
Publicado: (1997)

MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1
por: Liu, Xiaogang, et al.
Publicado: (2015)

Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
por: de Heer, Pieter, et al.
Publicado: (2008)

Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy
por: Rosas, Carlos, et al.
Publicado: (2014)

Effects of diclofenac and celecoxib on osteoclastogenesis during alveolar bone healing, in vivo
por: Ghalayani, Parichehr, et al.
Publicado: (2014)

Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells
por: Jiao, Jie, et al.
Publicado: (2013)

Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression
por: Rasouli, Sara, et al.
Publicado: (2018)

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
por: Hou, Xiao-lin, et al.
Publicado: (2015)

PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015)

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
por: Chu, Tian-Huei, et al.
Publicado: (2013)

Celecoxib in breast cancer prevention and therapy
por: Li, Jieqing, et al.
Publicado: (2018)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
por: Sobolewski, Cyril, et al.
Publicado: (2021)

Celecoxib prevents tumor necrosis factor-α (TNF-α)-induced cellular senescence in human chondrocytes
por: Wang, Qunli, et al.
Publicado: (2021)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

The elements of human cyclin D1 promoter and regulation involved
por: Guo, Zhi-yi, et al.
Publicado: (2011)

Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma
por: Hu, Jun-Wen, et al.
Publicado: (2020)

Synthesis of Novel Pyrazole Derivatives and Their Tumor Cell Growth Inhibitory Activity
por: Cui, Ying-Jie, et al.
Publicado: (2019)

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma
por: Li, Wei, et al.
Publicado: (2012)

SUMO Modification of Stra13 Is Required for Repression of Cyclin D1 Expression and Cellular Growth Arrest
por: Wang, Yaju, et al.
Publicado: (2012)

Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation
por: Huang, Xiao-hui, et al.
Publicado: (2014)

Cisplatin decreases cyclin D2 expression via upregulating miR-93 to inhibit lung adenocarcinoma cell growth
por: Xie, Ning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b2gr27i7ii50bl6b12p1ejog30